✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Onesource Specialty Pharma Ltd.

ONESOURCE

Market Cap
₹19,319 Cr.
P/E
0.00

Onesource Specialty Pharma Ltd.

About
Onesource Specialty is in the Pharmaceuticals sector with a M.cap of 19319.00 Cr and a PE ratio of 0.0.
Onesource Specialty is in the Pharmaceuticals sector with a M.cap of 19319.00 Cr and a… Read more
Low
1210
52W Range
High
1800
  • Onesource Specialty
  • Alembic Pharma
  • Astrazeneca Pharma I

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates
Custom financial statementNew
Edit rows
Forensics

2 Yes

Positive for this company

0 Neutral

Neutral for this company

3 No

Negative for this company

11 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Peer Comparison
FAQs on Onesource Specialty Pharma Ltd. Business

NA

Onesource Specialty major competitors are Alembic Pharma, Astrazeneca Pharma I, Eris Lifesciences, Caplin Point Lab, Jubilant Pharmova, Wockhardt, Concord Biotech.
Market Cap of Onesource Specialty is ₹19,319 Crs.
While the median market cap of its peers are ₹19,089 Crs.

Onesource Specialty seems to be less financially stable compared to its competitors.
Altman Z score of Onesource Specialty is 12.39 and is ranked 4 out of its 8 competitors.

View FAQ's On Shareprice
Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release Mar May
Investor Presentation
Conference Call Mar
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material